华康生物医学(08622)10月9日下午短暂停牌 待公布内幕消息

Core Viewpoint - Huakang Biomedical (08622) has announced that its shares will be suspended from trading on the Hong Kong Stock Exchange's GEM starting from October 9, 2025, at 1 PM, pending the release of an announcement containing insider information in accordance with the Hong Kong Code on Takeovers and Mergers [1] Summary by Category - Company Announcement - Huakang Biomedical's shares will be suspended from trading on the Hong Kong Stock Exchange's GEM [1] - The suspension is effective from October 9, 2025, at 1 PM [1] - The suspension is due to the pending announcement of insider information [1] - Regulatory Compliance - The company is acting in accordance with the Hong Kong Code on Takeovers and Mergers [1]